Trial Profile
Disease Activity at 3 Month Predicts the Clinical Response at 1 Year Treated by Tocilizumab in Patients with Active Rheumatoid Arthritis: Results from Observational Investigation of Daily Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 22 Jun 2016 Results published in the Clinical and Experimental Rheumatology
- 02 Sep 2015 New trial record